Management of Acute Kidney Injury in Patient with Dengue and COVID-19 Illness Simultaneously
Satish Mahajan, Vankadari Venkata Sesha Satya Sagar, Dhruv Talwar, Annadatha Akhilesh, Chitturi Venkata Sai Akhil
Journal of Pharmaceutical Research International · pp. 170–175 · Published 14 Dec 2021
10.9734/jpri/2021/v33i57A33981Abstract
Dengue is a viral illness spreads through the bite of Aedes aegypti mosquito leading to a serious health hazard. Dengue induced acute kidney injury is a fatal consequence and there are very few studies reported. Hence early identification of high risk groups is crucial for prevention, to restrict progression and effective treatment of acute kidney injury and to minimise associated morbidity and mortality. The coronavirus disease outbreak has widely spread into a pandemic all over the world. COVID-19 cases have presented with wide spectrum of severity ranging from a mild presentation to severe cases affecting the lungs(ARDS) mainly and rapidly affecting various body organs leading to multiorgan failure. Among these renal involvement is common, the severity of which ranges from mild loss of protein in urine to progressive acute kidney injury requiring renal replacement therapy.
References (10)
- 1 Management of acute kidney injury in patients with COVID-19 [DOI]
- 2 Acute kidney injury in critically ill patients with COVID-19 [DOI]
- 3 Characteristics and associated factors of acute kidney injury among adult dengue patients: A retrospective single-center study [DOI]
- 4 Dengue-associated acute kidney injury [DOI]
- 5 COVID-19 and acute kidney injury [DOI]
- 6 Acute Kidney Injury and Kidney Damage in COVID-19 Patients [DOI]
- 7 Defining acute kidney injury in dengue viral infection by conventional and novel classification systems (AKIN and RIFLE): a comparative analysis [DOI]
- 8 Fatal HELLP syndrome in pregnancy: A sequelae of Long COVID?
- 9 Type 2 myocardial infarction in COVID19: World's first case series
- 10 COVID-19 Induced Immunosuppression resulting in Pulmonary Mucormycosis : A Long COVID sequalae [DOI]
Cited by 4
Abhilash , Ruchira Ankar , Jaya Gawai , Roshan Uma · Journal of Pharmaceutical Negative Results · 2022
Aditya Nistane, Kavita Gomase, Roshan Umate · Journal of Pharmaceutical Negative Results · 2022
Shivani Ganjare, Ranjana Sharma, Roshan Umate · Journal of Pharmaceutical Negative Results · 2022
Manjari R. Ingle, S. Pohekar, Ruchira Ankar · Journal of Pharmaceutical Negative Results · 2022
Related research
- Development of Digital Surveillance for the COVID-19 and Dengue Co-Epidemic (SMART-CODEN) in Indonesia — shares topic coverage
- Hemoadsorption with CytoSorb in Pediatric Patient of Dengue Shock Syndrome: A Case Report — shares topic coverage
- Evolution of Severe Dengue in the Period Before and After the Covid-19 Pandemic — shares topic coverage
- Continued Circulation of DENV-2 (Genotype IV) in Delhi, India — shares topic coverage
- Prevalence of Dengue Virus and Malaria in Patients with Febrile Complaints in Kaduna Metropolis, Nigeria — shares topic coverage
Article metrics
Real usage data collected on this platform.
17
Page views
0
PDF downloads
1
Outbound clicks
4
Citations
Views over time
Views by country
Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".
Traffic sources
Referring site, by host.
Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.